About Breast Cancer and Diagnostic Methods
According to the American Cancer Society and National Cancer Institute, the facts surrounding breast cancer are as follows:
- 1-in-8 women will be diagnosed with breast cancer in her lifetime.
- Approximately 87% of women diagnosed with breast cancer have no family history or elevated genetic risk to developing breast cancer.
- An estimated 1-in-4 women diagnosed with breast cancer is under 49 years of age.
- Breast cancer found in women under 49 years of age is usually more aggressive.
- An estimated 20-25% of all breast cancers are missed by screening mammography, and that number is higher in premenopausal women and women with denser breast tissue and/or previous surgical procedures.
- Each year in the U.S. alone an estimated 210,000 women will be diagnosed with breast cancer and over 41,000 women will die.
Yet, the #1 statistic about breast cancer is this - It is 97% survivable with early detection.
The BT Test® provides an entirely new testing capability, at the molecular level, providing physicians with an additional analytical tool for their arsenal to help detect breast cancer earlier.
Clinical Research and Medical Information on BT Test®
The BT Test®, is not a genetic test. Rather, it detects and measures key blood-based protein biomarkers in the blood that are associated with breast cancer development and growth. Using a proprietary analytical relational algorithm, the test has demonstrated the ability to detect the actual presence of breast cancer with a high level of accuracy.
The BT Test® has successfully demonstrated in its clinical studies an accuracy of 97% in women 49 years of age and younger and 86% in women 50 years of age and older. The clinical studies involved both breast cancer-positive and non-breast cancer patients; the latter group being comprised of both healthy women and those with benign breast conditions.
Back to the top
|
